Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bone

Showing results (151-160 of 192) with videos related to

Pageof 20
Sort By:
Bone|April 20, 2010
Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral densityH K Genant, K Engelke, D A Hanley, et al.
Obstetrics and Gynecology|May 3, 2013
Use of depot medroxyprogesterone acetate contraception and incidence of bone fractureLee L Lanza, Lisa J McQuay, Kenneth J Rothman, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fracturesEthel S Siris, John P Bilezikian, Mishaela R Rubin, et al.
Annals of Internal Medicine|March 7, 2007
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trialSusan L Greenspan, Henry G Bone, Mark P Ettinger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 10, 2017
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM ExtensionNelson B Watts, Jacques P Brown, Socrates Papapoulos, et al.
Science (New York, N.Y.)|March 9, 2002
Antarctic krill under sea ice: elevated abundance in a narrow band just south of ice edgeAndrew S Brierley, Paul G Fernandes, Mark A Brandon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 26, 2000
Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of boneP Bianco, M Riminucci, A Majolagbe, et al.
BMC Musculoskeletal Disorders|April 29, 2017
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension studyJonathan D Adachi, Henry G Bone, Nadia S Daizadeh, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study GroupR P Tonino, P J Meunier, R Emkey, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2014
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonateJ P Brown, C Roux, P R Ho, et al.
Pageof 20

Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
Bone|April 20, 2010
Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral densityH K Genant, K Engelke, D A Hanley, et al.
Obstetrics and Gynecology|May 3, 2013
Use of depot medroxyprogesterone acetate contraception and incidence of bone fractureLee L Lanza, Lisa J McQuay, Kenneth J Rothman, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fracturesEthel S Siris, John P Bilezikian, Mishaela R Rubin, et al.
Annals of Internal Medicine|March 7, 2007
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trialSusan L Greenspan, Henry G Bone, Mark P Ettinger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 10, 2017
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM ExtensionNelson B Watts, Jacques P Brown, Socrates Papapoulos, et al.
Science (New York, N.Y.)|March 9, 2002
Antarctic krill under sea ice: elevated abundance in a narrow band just south of ice edgeAndrew S Brierley, Paul G Fernandes, Mark A Brandon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 26, 2000
Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of boneP Bianco, M Riminucci, A Majolagbe, et al.
BMC Musculoskeletal Disorders|April 29, 2017
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension studyJonathan D Adachi, Henry G Bone, Nadia S Daizadeh, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study GroupR P Tonino, P J Meunier, R Emkey, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2014
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonateJ P Brown, C Roux, P R Ho, et al.
Pageof 20